in 25 days Kaiser Permanente — Kaiser Northwest's Zepbound criteria move to the rev 10/08/2026 document — cite that version in an appeal from this date See the changelog
WalletNoise

Verified since Sep 5, 2026

What will your GLP-1 actually cost?

Every legal way to pay — manufacturer direct, savings cards, Medicare's GLP-1 Bridge, discount cards — ranked for your situation. Every price shows its source and the date we verified it.

  • Sourced and dated
  • No cookies, no ads
  • No account needed

Price my prescription

Your answers only shape the URL of your results page, so you can share or bookmark it. We keep no record of them — only running totals: how many times each drug was priced, and about how many readers a day that was.

The noise

Money is the side effect nobody warned you about.

  1. 2:14 AM

    Can I afford March?

  2. 2:31 AM

    When does my savings card cap out?

  3. 3:02 AM

    Does my coverage die January 1?

  4. 3:20 AM

    Is there a cheaper way I don't know about?

That's wallet noise. You're not disorganised — the pricing is. There are five legal ways to pay for the same drug, each with its own eligibility, annual cap and expiry date. Which one is cheapest changes with your dose, your plan and the month. Three of those changes are already dated on the calendar below. Nobody hands you this on one page, so we built one.

56% of people taking a GLP-1 said it was hard to afford; among those with insurance, 27% paid the full cost themselves, and 14% have stopped over the price. KFF Health Tracking Poll, November 2025

Wherever you are in the loop, start here

Or browse every priced page — all five drugs, every dose, every coverage situation.

Next 90 days

Dated changes already on the calendar

Full changelog
  1. Kaiser Permanente — Kaiser Northwest's Zepbound criteria move to the rev 10/08/2026 document — cite that version in an appeal from this date healthy.kaiserpermanente.orgin 25 days
  2. Blue Cross Blue Shield Federal Employee Program (FEP) — 2027 drug lists published for open season and the weight-loss class carries over unchanged: Zepbound still under DRUGS NOT COVERED on Standard and Basic, Wegovy injection and tablets plus Wegovy HD still Tier 3 with PA, Saxenda Tier 3, generic liraglutide Tier 1, Foundayo still absent caremark.comin 40 days
  3. Express Scripts (Evernorth / Cigna) — The 2027 National Preferred Formulary keeps the weight-loss class exactly as 2026 left it: Zepbound KwikPens and vials excluded, with liraglutide, Foundayo, Wegovy HD, Wegovy pens, Wegovy tablets and Zepbound pens as the preferred alternatives, and Saxenda excluded in favour of generic liraglutide. Nothing you have to do changes on this date — but cite the 2027 exclusions list, not the 2026 one, in an appeal about a 2027 fill express-scripts.comin 40 days

Sourced, dated, or absent

If we can't verify a price against a primary source, we say so instead of guessing. Every figure here carries the date we last read its source, and none of them is older than Sep 5, 2026.

Coverage policy, decoded

PA criteria, step therapy, and appeal deadlines for the major PBMs — from their own documents. Browse policies.

Denied? Know your clock

Deadlines run from the date on your denial notice and differ by coverage type — Medicare's changed in 2026, so many guides are stale. See the deadlines and their sources.

A woman in her fifties at a sunlit kitchen table, reading a letter beside a mug of coffee

We read every PBM's criteria document so you don't have to

Ten payers, their own published PA criteria, step-therapy rules, quantity limits and appeal routes — transcribed by hand, graded for confidence, and dated. Where a payer publishes nothing, we say so rather than filling the gap.

Browse coverage policies